Skip to content

AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma

A Multicenter Clinical Study to Validate the Performance Improvement of Fundus Photography Reading Software

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07318428
Enrollment
10
Registered
2026-01-06
Start date
2026-02-20
Completion date
2026-05-22
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Glaucoma Suspect, Retinal Vein Occlusion

Brief summary

The purpose of this multi-center study is to evaluate the extent to which AI-assisted fundus image interpretation improves the diagnostic performance of ophthalmologists. Rather than assessing the standalone algorithm performance, this study aims to determine the clinical value of using AI as a decision-support tool within actual clinical workflows. At each participating institution, five ophthalmologists within three years of board certification and five ophthalmology residents will participate as readers. All readers will interpret fundus images both with and without the AI-based assistance software. The study will quantitatively compare diagnostic accuracy and reading time across the two conditions for four posterior segment diseases: diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and glaucoma.

Interventions

DEVICEVUNO Med-Fundus AI

The intervention consists of an AI-based fundus image interpretation software that provides automated outputs for 12 retinal and optic nerve findings (e.g., hemorrhage, exudates, drusen, optic disc change). The system does not generate a direct disease diagnosis. Instead, the AI displays the presence or absence of 12 predefined findings along with their lesion locations. Readers may use this finding-level information as decision-support when determining the presence of the four target diseases (diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and glaucoma).

Sponsors

Inje University
Lead SponsorOTHER
Dong-A University Hospital
CollaboratorOTHER
Kosin University Gospel Hospital
CollaboratorOTHER
Pusan National University Hospital
CollaboratorOTHER
Pusan National University Yangsan Hospital
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Ten readers will be recruited from five participating hospital sites, consisting of: * Five ophthalmologists within three years of board certification * Five ophthalmology residents Ophthalmologists and residents of any age, sex, race, or ethnicity may participate as study readers. All readers must meet the following inclusion criteria: * Licensed physicians qualified to interpret fundus images. * Ophthalmologists within three years of board certification, or ophthalmology residents with no restriction on clinical experience. * Able and willing to complete both the unassisted and AI-assisted reading sessions. * Able to provide informed consent for participation in the reader study. * Affiliated with one of the participating clinical sites.

Design outcomes

Primary

MeasureTime frameDescription
Performance of readers with and without AI assistance: SensitivityThrough study completion, approximately 2 monthsSensitivity of reader diagnoses for each of the four target diseases (DR, AMD, RVO, glaucoma) and for any fundus abnormality will be assessed with and without AI assistance, using the image-level reference standard as the comparator, through two reading sessions in which all 10 readers review all cases-randomised for each reader-with a washout period implemented to mitigate recall bias.
Performance of readers with and without AI assistance: SpecificityThrough study completion, approximately 2 monthsSpecificity of reader diagnoses for each of the four target diseases (DR, AMD, RVO, glaucoma) and for any fundus abnormality will be assessed with and without AI assistance, using the image-level reference standard as the comparator, through two reading sessions in which all 10 readers review all cases-randomised for each reader-with a washout period implemented to mitigate recall bias.
Reading time per imageThrough study completion, approximately 2 monthsReading time per image will be measured during both unassisted and AI-assisted interpretation sessions. For each case, the total time from the moment the image is displayed to the moment the reader submits the final disease classification will be recorded automatically by the reading platform. Mean reading time per image will be calculated for each reader and compared between the two conditions to evaluate whether AI assistance reduces interpretation time.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026